Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3434.01 | 1445 / 1445 | 62% | 0.93 | 113 / 183 |
brain | 100% | 2716.26 | 2638 / 2642 | 45% | 0.71 | 314 / 705 |
ovary | 100% | 3388.94 | 180 / 180 | 43% | 0.69 | 184 / 430 |
stomach | 100% | 2834.87 | 359 / 359 | 36% | 0.57 | 104 / 286 |
intestine | 100% | 3975.56 | 966 / 966 | 31% | 0.50 | 165 / 527 |
kidney | 100% | 4063.27 | 89 / 89 | 22% | 0.34 | 195 / 901 |
bladder | 100% | 3514.90 | 21 / 21 | 18% | 0.28 | 92 / 504 |
thymus | 100% | 4321.59 | 653 / 653 | 14% | 0.18 | 82 / 605 |
uterus | 100% | 3838.30 | 170 / 170 | 13% | 0.17 | 61 / 459 |
lung | 100% | 3263.02 | 578 / 578 | 12% | 0.17 | 144 / 1155 |
skin | 100% | 3080.40 | 1808 / 1809 | 8% | 0.12 | 39 / 472 |
adrenal gland | 100% | 4277.04 | 258 / 258 | 7% | 0.10 | 17 / 230 |
pancreas | 100% | 1994.93 | 328 / 328 | 6% | 0.07 | 10 / 178 |
prostate | 100% | 3825.07 | 245 / 245 | 3% | 0.04 | 16 / 502 |
breast | 100% | 3516.61 | 459 / 459 | 3% | 0.04 | 34 / 1118 |
liver | 100% | 1977.85 | 226 / 226 | 2% | 0.03 | 8 / 406 |
adipose | 100% | 3480.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 6100.31 | 803 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 3488.78 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 4490.94 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3727.05 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2743.97 | 856 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.28 | 7 / 29 |
eye | 0% | 0 | 0 / 0 | 4% | 0.04 | 3 / 80 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007254 | Biological process | JNK cascade |
GO_1900045 | Biological process | negative regulation of protein K63-linked ubiquitination |
GO_0050859 | Biological process | negative regulation of B cell receptor signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0035360 | Biological process | positive regulation of peroxisome proliferator activated receptor signaling pathway |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0019216 | Biological process | regulation of lipid metabolic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0010875 | Biological process | positive regulation of cholesterol efflux |
GO_0046329 | Biological process | negative regulation of JNK cascade |
GO_0034122 | Biological process | negative regulation of toll-like receptor signaling pathway |
GO_0045598 | Biological process | regulation of fat cell differentiation |
GO_0010804 | Biological process | negative regulation of tumor necrosis factor-mediated signaling pathway |
GO_0030183 | Biological process | B cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0098780 | Biological process | response to mitochondrial depolarisation |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0005829 | Cellular component | cytosol |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0005095 | Molecular function | GTPase inhibitor activity |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0030332 | Molecular function | cyclin binding |
Gene name | GPS2 |
Protein name | GPS2 protein G protein pathway suppressor 2 G protein pathway suppressor 2 (GPS-2) |
Synonyms | |
Description | FUNCTION: Key regulator of inflammation, lipid metabolism and mitochondrion homeostasis that acts by inhibiting the activity of the ubiquitin-conjugating enzyme UBE2N/Ubc13, thereby inhibiting 'Lys-63'-linked ubiquitination (By similarity). In the nucleus, can both acts as a corepressor and coactivator of transcription, depending on the context . Acts as a transcription coactivator in adipocytes by promoting the recruitment of PPARG to promoters: acts by inhibiting the activity of the ubiquitin-conjugating enzyme UBE2N/Ubc13, leading to stabilization of KDM4A and subsequent histone H3 'Lys-9' (H3K9) demethylation (By similarity). Promotes cholesterol efflux by acting as a transcription coactivator . Acts as a regulator of B-cell development by inhibiting UBE2N/Ubc13, thereby restricting the activation of Toll-like receptors (TLRs) and B-cell antigen receptors (BCRs) signaling pathways (By similarity). Acts as a key mediator of mitochondrial stress response: in response to mitochondrial depolarization, relocates from the mitochondria to the nucleus following desumoylation and specifically promotes expression of nuclear-encoded mitochondrial genes . Promotes transcription of nuclear-encoded mitochondrial genes by inhibiting UBE2N/Ubc13 . Can also act as a corepressor as part of the N-Cor repressor complex by repressing active PPARG . Plays an anti-inflammatory role in macrophages and is required for insulin sensitivity by acting as a corepressor (By similarity). Plays an anti-inflammatory role during the hepatic acute phase response by interacting with sumoylated NR1H2 and NR5A2 proteins, thereby preventing N-Cor corepressor complex dissociation . In the cytosol, also plays a non-transcriptional role by regulating insulin signaling and pro-inflammatory pathways (By similarity). In the cytoplasm, acts as a negative regulator of inflammation by inhibiting the pro-inflammatory TNF-alpha pathway; acts by repressing UBE2N/Ubc13 activity (By similarity). In the cytoplasm of adipocytes, restricts the activation of insulin signaling via inhibition of UBE2N/Ubc13-mediated ubiquitination of AKT (By similarity). Able to suppress G-protein- and mitogen-activated protein kinase-mediated signal transduction . Acts as a tumor-suppressor in liposarcoma . .; FUNCTION: (Microbial infection) Required for efficient replication of hepatitis C virus (HCV) by promoting the interaction between VAPA and HCV virus protein NS5A. . |
Accessions | ENST00000673265.1 [Q13227-1] ENST00000574458.1 I3L3Y9 ENST00000570780.5 ENST00000573684.5 I3L242 ENST00000577040.2 ENST00000672046.1 [Q13227-1] I3L4X7 Q3SY98 ENST00000380728.7 [Q13227-1] Q13227 I3L1H4 ENST00000389167.9 [Q13227-1] |